ArticleThe journal of liquid biopsy2026

Development of a LiDia-SEQ™ platform compatible breast cancer panel and testing with metastatic breast cancer patient samples: A rapid, sample-to-result, fully integrated next-generation sequencing (NGS)-based platform, LiDia-SEQ, for use at the point-of-need.

Mohammadali Yavari Ramsheh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.